FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Jefferies lowered its price target on CVS Health (NYSE: CVS) to $76.00 (from $86.00) while maintaining a Hold rating. CVS reported Q3 EPS of $1.50 that beat consensus by $0.02. Similar to the last few quarters, SSS revs were pressured by weakness in front-end sales and the... More
Leerink Partners lowered its price target on CVS Health (NYSE: CVS) to $85.00 (from $90.00) while maintaining an Outperform rating.
Analyst David Larsen notes volumes starting to show some improvement and the company is responding aggressively to Amazon.
In the quarter same-store... More

